From: A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia
Median number of drugs received | p-value (MWU) | Proportion of polypharmacy (≥5 drugs) | p-value (CHI2) | ||
---|---|---|---|---|---|
Total sample | N=191 | 4 (2-6) | n=95; 50% | ||
Age | |||||
<65 years | n=38; 20% | 3 (2-5) | 0.011* | n=13; 34% | 0.032* |
≥65 years | n=153; 80% | 5 (3-7) | n=82; 54% | ||
Living Situation | |||||
HC | n=88; 46% | 4 (2-6) | 0.001* | n=32; 36% | 0.001* |
LTC | n=103; 54% | 5 (4-7) | n=63; 61% | ||
Sex | |||||
female | n=106; 56% | 5 (2-6) | 0.480 | n=57; 54% | 0.213 |
male | n=85; 44% | 4 (2-6) | n=38; 45% | ||
Dementia onset | |||||
YOD | n=93; 49% | 4 (2-6) | 0.068 | n=42; 45% | 0.218 |
LOD | n=98; 51% | 5 (3-7) | n=53; 54% |